Form 4 for LRCX Lam Research
Accepted 2025-10-14 00:00:00 ET · period of report 2025-10-13 · accession 0001707826-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-14 | 2025-10-13 | LRCX | Vahedi Vahid | SVP | S - Sale | $138.90 | -52.2K | 251.0K | -17% | -$7.25M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-13 | S | D | 52,190 | $138.90 | 251,047 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2025. (F2) The amount reported includes shares subject to unvested restricted stock units. |